JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1851
Synaptics
SYNA
$4.21B
| $13.6M | ﹤0.01% |
115,612
-3,409
| -3% | -$500K |
2013 Q2
36 quarters
|
|
1852
Magnolia Oil & Gas
MGY
$6.48B
| $13.6M | ﹤0.01% |
648,350
-510,729
| -44% | -$12.8M |
2019 Q2
12 quarters
|
|
1853
NewMarket
NEU
$8.47B
| $13.6M | ﹤0.01% |
45,180
-2,855
| -6% | -$923K |
2013 Q2
36 quarters
|
|
|
AVTA
1854
DELISTED
Avantax, Inc. Common Stock
AVTA
| $13.6M | ﹤0.01% |
736,620
+265,298
| +56% | +$4.82M |
2013 Q2
36 quarters
|
|
1855
GameStop
GME
$12.2B
| $13.6M | ﹤0.01% |
444,324
+12,768
| +3% | +$406K |
2013 Q2
36 quarters
|
|
1856
Prudential
PUK
$30.5B
| $13.5M | ﹤0.01% |
539,486
-167
| -0% | -$4.29K |
2013 Q2
36 quarters
|
|
1857
FNB Corp
FNB
$6.14B
| $13.5M | ﹤0.01% |
1,246,383
+74,393
| +6% | +$869K |
2013 Q2
36 quarters
|
|
|
MAG
1858
DELISTED
MAG Silver
MAG
| $13.5M | ﹤0.01% |
1,108,697
+33,905
| +3% | +$496K |
2015 Q4
26 quarters
|
|
|
TBI
1859
Trueblue
TBI
$289M
| $13.5M | ﹤0.01% |
753,266
-86,319
| -10% | -$2.03M |
2013 Q2
36 quarters
|
|
1860
PUT
American Tower
AMT
$75B
| $13.4M | ﹤0.01% |
52,600
-11,400
| -18% | -$2.86M |
2021 Q2
4 quarters
|
|
1861
CALL
Albertsons Companies
ACI
$5.69B
| $13.4M | ﹤0.01% |
+500,000
| New | +$15.3M |
2022 Q2
0 quarters
|
|
1862
Prestige Consumer Healthcare
PBH
$2.12B
| $13.4M | ﹤0.01% |
227,218
+16,976
| +8% | +$936K |
2013 Q2
36 quarters
|
|
1863
Royal Gold
RGLD
$19.7B
| $13.4M | ﹤0.01% |
125,090
+1,335
| +1% | +$165K |
2013 Q2
36 quarters
|
|
1864
Logitech
LOGI
$14.8B
| $13.4M | ﹤0.01% |
256,466
+32,953
| +15% | +$2.03M |
2013 Q2
36 quarters
|
|
1865
Personalis
PSNL
$1.73B
| $13.3M | ﹤0.01% |
3,859,746
-390,459
| -9% | -$1.99M |
2019 Q2
12 quarters
|
|
1866
CALL
Mondelez International
MDLZ
$73.7B
| $13.3M | ﹤0.01% |
214,100
+112,900
| +112% | +$7.13M |
2021 Q2
4 quarters
|
|
1867
CALL
Dollar Tree
DLTR
$21.5B
| $13.3M | ﹤0.01% |
85,200
+60,100
| +239% | +$9.52M |
2021 Q1
5 quarters
|
|
1868
Lattice Semiconductor
LSCC
$18.3B
| $13.3M | ﹤0.01% |
273,668
-114,371
| -29% | -$5.7M |
2016 Q4
22 quarters
|
|
1869
Clean Harbors
CLH
$16.5B
| $13.3M | ﹤0.01% |
151,314
-2,669
| -2% | -$258K |
2013 Q2
36 quarters
|
|
1870
Axos Financial
AX
$4.97B
| $13.2M | ﹤0.01% |
368,608
-61,922
| -14% | -$2.38M |
2013 Q2
36 quarters
|
|
1871
Donaldson
DCI
$10.2B
| $13.2M | ﹤0.01% |
273,241
+95,644
| +54% | +$4.82M |
2013 Q2
36 quarters
|
|
1872
CALL
Legend Biotech
LEGN
$3.76B
| $13.1M | ﹤0.01% |
238,500
| – | – |
2022 Q1
1 quarter
|
|
1873
Arcus Biosciences
RCUS
$3.21B
| $13.1M | ﹤0.01% |
517,192
+81,399
| +19% | +$1.99M |
2018 Q1
17 quarters
|
|
1874
Kulicke & Soffa
KLIC
$5.03B
| $13.1M | ﹤0.01% |
306,076
+26,499
| +9% | +$1.31M |
2013 Q2
36 quarters
|
|
1875
SLM Corp
SLM
$4.25B
| $13.1M | ﹤0.01% |
821,252
-5,198
| -0.6% | -$90K |
2013 Q2
36 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.